Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

aurobindo pharma news

Tag: aurobindo pharma news

Read all Latest developments, information and news on and about Aurobindo Pharmaceuticals - Page 6

Aurobindo Pharma is a pharmaceutical manufacturing company headquartered in Hyderabad manufacturing generic pharmaceuticals and active pharmaceutical ingredients. - Latest Updates

Aurobindo Pharma arm CuraTeQ Biologics completes successful Phase 1 Pharmacokinetics study of bone drug

Aurobindo Pharma arm bags USFDA nod for Testosterone Cypionate Injection

Ruchika Sharma23 Oct 2023 12:30 PM IST

Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary company, Eugia Pharma Specialities Limited, has received...

Aurobindo Pharma, Sun Pharma recall Rasagiline Tablets, Cequa from US market

Ruchika Sharma9 Oct 2023 12:30 PM IST

The US health regulator stated that Aurobindo Pharma is recalling 9,890 bottles of Rasagiline Tablets, a medication indicated for the treatment of...

Aurobindo Pharma arm CuraTeQ Biologics gets positive opinion for biosimilar Dazublys from EMA

Aurobindo Pharma arm, Hilleman Labs Singapore ink pact for paediatric pentavalent vaccine

Ruchika Sharma28 Sept 2023 12:30 PM IST

Telangana: Through a recent BSE filing, Aurobindo Pharma has informed that Auro Vaccines Private Limited, a wholly-owned subsidiary of the...

Marksans Pharma arm New York facility gets 1 USFDA observation

USFDA issues 1 observation for Aurobindo Pharma arm AP facility

Ruchika Sharma20 Sept 2023 10:00 AM IST

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has issued a ‘Form 483’ with 1 observation at...

Aurobindo Pharma gets USFDA EIR for Telangana facility

Ruchika Sharma8 Sept 2023 10:30 AM IST

Hyderabad: Aurobindo Pharma has announced that the company has received an Establishment Inspection Report (EIR) from United States Food and Drug...

Aurobindo Pharma, Alembic Pharma recall drugs in US over manufacturing lapses

Ruchika Sharma21 Aug 2023 4:58 PM IST

New Delhi: Alembic Pharmaceuticals and Aurobindo Pharma are recalling different products in the US market due to manufacturing lapses, according to...

USFDA tentative nod to Aurobindo Pharma's generic FDC drug to treat HIV in children

Ruchika Sharma17 Aug 2023 1:30 PM IST

Aurobindo has capacities in their FDA approved plant to meet the market demand for this product and commercial production will commence in Q3 FY24.

Caplin Steriles gets USFDA nod for Procainamide Hydrochloride Injection for treating abnormal heart rhythm

Aurobindo Pharma arm secures USFDA okay for Icatibant Injection

Ruchika Sharma16 Aug 2023 2:30 PM IST

Icatibant Injection is indicated for treatment of acute attacks of hereditary angioedema in adults 18 years of age and older.

Q1 Results: Aurobindo Pharma consolidated net profit increases 10 percent to Rs 571 crore

Ruchika Sharma15 Aug 2023 11:30 AM IST

Hyderabad: Aurobindo Pharma has said its consolidated net profit increased 10 per cent to Rs 571 crore in the first quarter ended June 30, 2023, on...

Aurobindo Pharma arm bags USFDA nod for Vancomycin Hydrochloride for Injection

Ruchika Sharma7 Aug 2023 11:32 AM IST

Vancomycin Hydrochloride for Injection USP is indicated in adults and paediatric patients (neonates and older) for the treatment of Septicemia,...

USFDA concludes inspection at Aurobindo Pharma Telangana facility with zero observations

Ruchika Sharma5 Aug 2023 11:49 AM IST

Telangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has concluded the Pre-Approval Inspection (PAI)...

Aurobindo Pharma bags USFDA nod for Saxagliptin Tablets

Ruchika Sharma1 Aug 2023 2:45 PM IST

Saxagliptin Tablets, 2.5 mg and 5 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok